Business Description
Kronos Bio Inc
NAICS : 541714
SIC : 2833
ISIN : US50107A1043
Share Class Description:
KRON: Ordinary SharesDescription
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.12 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -0.24 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -3.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26.1 | |||||
| 3-Year EPS without NRI Growth Rate | 28.9 | |||||
| 3-Year FCF Growth Rate | 22.2 | |||||
| 3-Year Book Growth Rate | -32.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.99 | |||||
| 9-Day RSI | 36.11 | |||||
| 14-Day RSI | 38.56 | |||||
| 6-1 Month Momentum % | 35.23 | |||||
| 12-1 Month Momentum % | -10.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.24 | |||||
| Quick Ratio | 7.24 | |||||
| Cash Ratio | 7.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.9 | |||||
| Shareholder Yield % | 4.38 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1937.5 | |||||
| Net Margin % | -1791.87 | |||||
| FCF Margin % | -1260.51 | |||||
| ROE % | -55.72 | |||||
| ROA % | -43.47 | |||||
| ROIC % | -207.01 | |||||
| ROC (Joel Greenblatt) % | -360.29 | |||||
| ROCE % | -51.77 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 9.14 | |||||
| PB Ratio | 0.37 | |||||
| Price-to-Tangible-Book | 0.37 | |||||
| EV-to-EBIT | 0.7 | |||||
| EV-to-Forward-EBIT | -0.07 | |||||
| EV-to-EBITDA | 0.72 | |||||
| EV-to-Revenue | -13.65 | |||||
| EV-to-FCF | 1.08 | |||||
| Price-to-Net-Current-Asset-Value | 0.47 | |||||
| Price-to-Net-Cash | 0.5 | |||||
| Earnings Yield (Greenblatt) % | 142.86 | |||||
| FCF Yield % | -131.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KRON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kronos Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6.288 | ||
| EPS (TTM) ($) | -1.95 | ||
| Beta | 1.8 | ||
| Volatility % | 68.35 | ||
| 14-Day RSI | 38.56 | ||
| 14-Day ATR ($) | 0.084669 | ||
| 20-Day SMA ($) | 1.1105 | ||
| 12-1 Month Momentum % | -10.86 | ||
| 52-Week Range ($) | 0.731 - 2.29 | ||
| Shares Outstanding (Mil) | 60.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kronos Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kronos Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kronos Bio Inc Frequently Asked Questions
What is Kronos Bio Inc(KRON)'s stock price today?
The current price of KRON is $1.00. The 52 week high of KRON is $2.29 and 52 week low is $0.73.
When is next earnings date of Kronos Bio Inc(KRON)?
The next earnings date of Kronos Bio Inc(KRON) is 2024-05-10 Est..
Does Kronos Bio Inc(KRON) pay dividends? If so, how much?
Kronos Bio Inc(KRON) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers